News

A new study finds hepatitis C virus (HCV) infection to be associated with a 70% increased rate of mortality in in-hospital patients with invasive pneumococcal disease (IPD).

Can genetic modification aid us in fighting mosquito-borne diseases?

The National Institute of Allergy and Infectious Diseases (NIAID) has partnered up with nonprofit foundation FUNSALUD to launch a study that will examine the effects of Zika infection in infants and children living in Guatemala.

A new biological fingerprint for tuberculosis meningitis in children may eventually help practitioners learn more on the severity of infection in their patients, which in turn can lead to better treatment decisions.

A new report on a measles outbreak that occurred in Ontario in 2015 emphasizes the importance of immunization in a globalized world.

Pleuromutilin antibiotics, meningococcal disease, tuberculosis, a new fluoroquinolone to treat acute bacterial skin and skin structure infections, and WHO’s position on HPV vaccine recommendations makes up this week’s Top 5 articles.

As researchers discover Chikungunya-carrying mosquitoes in Brazil, a new study analyzes the impact of the Zika virus on the area.

A new Johns Hopkins study finds that one fifth of hospitalized adults experience adverse effects from prescribed antibiotics; one fifth of those effects occurred in patients who should not have been prescribed antibiotics in the first place.

Building on lessons learned from the 2009 influenza A (H1N1) pandemic, the United States Department of Health and Human Services has released its updated Pandemic Influenza Plan for 2017-2027.

An infection control intervention coming from the VHA resulted in a significant reduction of MRSA in veteran living centers.

Seniors are at increased risk of hepatitis B, hepatitis C, and HIV. Prevention and early detection of potential infection are critical to avoiding long-term impact.

The results of a recent Phase IB study show that the novel Ebola vaccine, V920, was well-tolerated and “stimulated a rapid onset of binding and neutralizing antibodies,” which persisted for up to 1 year.

A new $25 fee for HIV and STI tests in Mississippi may be just one more barrier to testing faced by a low-income, high-risk population.

The CDC just released a study outlining areas where an increase of Aedes mosquitoes was observed in 2016. In addition, researchers report on Zika-related complications observed in 7 infants, postmortem.

Health officials in New York City are seeing the first West Nile virus-positive mosquitoes of the season as Los Angeles County reports its first human case of the year, marking new West Nile activity in the country’s biggest urban areas.

Six members of the Presidential Advisory Council on HIV/AIDS (PACHA) recently resigned in protest of the current administration’s healthcare policy.

WHO releases recommendations regarding HPV vaccination as primary preventive intervention against cervical cancer.

Researchers discover a new approach for measuring how long it takes an antibiotic to kill bacteria.

Commentary authors warn that lack of access to antibiotics to treat common bacterial infections are becoming difficult to access due to manufacturers finding them less profitable to produce and market; this can have serious implications.

Researchers from Yale University have come up with a new “chemical process” that may aid in the development of a new class of antibiotics.

Badela, a new antibiotic developed by Melinta Therapeutics, was just approved by the US FDA to treat acute bacterial skin and skin structure infections.

The CDC examines the high incidence of meningococcal disease in the “meningitis belt,” found within sub-Saharan Africa, and the efforts of the Meningitis Vaccine Project to monitor the impact of a meningococcal A conjugate vaccine.

The results of a new study suggest a link between vitamin A and tuberculosis.

Researchers from the UNC Lineberger Comprehensive Cancer Center elucidate the mode of action of #NS5A inhibitors, and learn more about the half-life of RCs in hepatitis C viruses.

New drugs for HIV, the growing rate of antibiotic resistance, a new hepatitis C treatment option, and updates on the Ebola outbreak and Lyme disease diagnostics, make up the Top 5 articles for this week.

The Centers for Disease Control and Prevention recently released a report on the cases of 2 infants who contracted Legionnaires’ disease during water births.

Two adults were hospitalized in Maine as a result of Powassan virus encephalitis.

Amesh A. Adalja, MD, FIDSA argues that a bill being considered in the Pennsylvania state legislature will ultimately result in increased antibiotic resistance and will set back the clock for finding appropriate treatments for Lyme disease.